Invivoscribe PCR/CE tests for lymphoproliferative diseases
Standardized tools for detection and monitoring of lymphoproliferative diseases
Invivoscribe exclusively offers a comprehensive selection of PCR-based assays for ABI fluorescence detection, including targeted FLT3 mutation assays, B- and T-cell clonality assays (based on EuroClonality/BIOMED-2 Concerted Action BMH4-CT98-3936), and translocation assays.
Leukemias and lymphomas originate from the malignant transformation of individual lymphoid cells, all leukemias and lymphomas generally share one or more cell-specific or “clonal” antigen receptor gene rearrangements. Therefore, tests that detect clonal rearrangements can be useful in the study of B- and T-cell malignancies.
Product is available in the following countries:
Links and documents
Keywordscancer clonality PCR translocation
Annika LuknerRegional Sales Representative, Estoniaannika.email@example.com +372 5554 4314
Atis ŠtālsRegional Sales Representative, Latviaatis.firstname.lastname@example.org +371 26 430 759
Vidas PečiukėnasRegional Sales Representative, Lithuaniavidas.email@example.com +370 69 880 122
Laura PietolaProduct Specialistlaura.firstname.lastname@example.org +358 50 584 9842